Effettuare il login Iscriviti gratis

RepliCel Life Sciences Ret. sull'asset

Cos'è Ret. sull'asset di RepliCel Life Sciences?

Ret. sull'asset di RepliCel Life Sciences, Inc. è -52.42%

Qual è la definizione di Ret. sull'asset?



Il rendimento delle attività indica quanto redditizie le attività di un'azienda stanno generando entrate. Viene calcolato dividendo il reddito netto per il patrimonio medio totale.

The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.

Ret. sull'asset di aziende nel Health Care settore su TSXV rispetto a RepliCel Life Sciences

Cosa fa RepliCel Life Sciences?

RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.

Aziende con ret. sull'asset simili a RepliCel Life Sciences